METHOD FOR PREVENTION OF INFECTIOUS-INFLAMMATORY COMPLICATIONS OF TRANSANAL ENDOSCOPIC RESECTION OF RECTUM FOR TUMOURS Russian patent published in 2016 - IPC A61B17/03 A61K31/4184 A61K33/14 A61K38/21 A61P35/00 A61M5/32 

FIELD: medicine.

SUBSTANCE: invention can be used for prevention of infectious-inflammatory complications during transanal endoscopic resection of rectum apropos benign and malignant tumours. For this purpose during transanal endoscopic resection of rectum under the condition of intestinal content ingress into the mezorectal cellular tissue, presence of inflammatory changes of the rectal wall in the area of the tumour, the mezorectal cellular tissue is infiltrated with 20 ml of ozonised physiologic saline in the amount of 1000 mcg/l. Then a preparation of interferon alpha 1 is introduced into the mezorectal cellular tissue in the amount of 1 million IU. After that, mezorectal cellular tissue is sprayed with 1 gram of metronidazole powder. Then, at the following stage, the rectal wall is closed in a standard way.

EFFECT: simple to implement method enables to individualise the therapeutic approach when predicting a high risk of development of infectious-inflammatory complications, ensuring a reduced rate of complications development and of the rate of rectum rhaphes lack.

1 cl, 2 ex